Brief: Neurogene Q3 EPS USD -0.99
13/11/2025 22:10
Nov 13 (Reuters) - Neurogene Q3 net income USD -20.953 million. Q3 operating expenses USD 23.798 million Q3 operating income USD -23.798 million
Recent news on Neurogene
See all newsBrief: Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Neurogene Inc reports results for the quarter ended June 30 - Earnings Summary
Neurogene Q2 adjusted loss per share misses estimates on employee costs
Neurogene Inc expected to post a loss of $1.42 a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Kroger, Meta, Sable